Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for Arterial Stiffness in Systemic Sclerosis
NCT02480335Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2015
- Primary completion
- Jul 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bosentan in systemic sclerosis (SSc), sponsored by University Medical Center Groningen. Started Jun 2015; status: completed.
02
Drugs
bosentan
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT02480335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02480335.